Combination Chemotherapy with Cisplatin, Pemetrexed, and Nivolumab for Malignant Pleural Mesothelioma: A Trial in Progress

被引：0
|
作者：
Fujimoto, N. [1 ]
Aoe, K. [2 ]
Kozuki, T. [3 ]
Oze, I. [4 ]
Kato, K. [5 ]
Kishimoto, T. [1 ]
Hotta, K. [6 ]
机构：
[1] Okayama Rosai Hosp, Okayama, Japan
[2] Yamaguchi Ube Med Ctr, Ube, Yamaguchi, Japan
[3] Shikoku Canc Ctr Hosp, Matsuyama, Ehime, Japan
[4] Aichi Canc Ctr, Res Inst, Nagoya, Aichi, Japan
[5] Kawasaki Med Coll, Okayama, Japan
[6] Okayama Univ Hosp, Okayama, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
programmed death-1; immune checkpoint inhibitor; asbestos;
D O I：
10.1016/j.jtho.2018.08.1265
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.06-10
引用
收藏
页码：S746 / S746
页数：1
相关论文
共 50 条
  • [21] Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma
    Janne, Pasi A.
    Simon, George R.
    Langer, Corey J.
    Taub, Robert N.
    Dowlati, Afshin
    Fidias, Panos
    Monberg, Matthew
    Obasaju, Coleman
    Kindler, Hedy
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (09) : 1465 - 1471
  • [22] Pemetrexed in malignant pleural mesothelioma
    Hazarika, M
    White, RM
    Booth, BP
    Wang, YC
    Ham, DYL
    Liang, CY
    Rahman, A
    Gobburu, JVS
    Li, N
    Sridhara, R
    Morse, DE
    Lostritto, R
    Garvey, P
    Johnson, JR
    Pazdur, R
    CLINICAL CANCER RESEARCH, 2005, 11 (03) : 982 - 992
  • [23] Pemetrexed and malignant pleural mesothelioma
    Marangolo, M.
    Vertogen, B.
    ANNALS OF ONCOLOGY, 2006, 17 : V103 - V105
  • [24] Significant response to carboplatin/pemetrexed chemotherapy in malignant pleural mesothelioma
    Futtam, L.
    Carney, D.
    McCaffrey, J.
    LUNG CANCER, 2010, 67 : S20 - S20
  • [25] A Retrospective Study of Chemotherapy with and without Pemetrexed in Malignant Pleural Mesothelioma
    Higashiguchi, Masayoshi
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Kobayashi, Masashi
    Goya, Sho
    Okamoto, Norio
    Matsuura, Yuka
    Tamiya, Motohiro
    Morishita, Naoko
    Tsumori, Teppei
    Kawase, Ichiro
    ANTICANCER RESEARCH, 2012, 32 (02) : 609 - 613
  • [26] Pemetrexed in combination with carboplatin in elderly patients with malignant pleural mesothelioma
    Ceresoli, G. L.
    Castagneto, B.
    Zucali, P. A.
    Favaretto, A. G.
    Mencoboni, M.
    De Giovanni, D.
    Cortinovis, D.
    Marangolo, M.
    Grossi, F.
    Del Conte, G.
    Ceribelli, A.
    Bearz, A.
    Muzio, A.
    Santoro, A.
    LUNG CANCER, 2006, 54 : S46 - S46
  • [27] PEMETREXED IN COMBINATION WITH CARBOPLATIN IN THE TREATMENT OF PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA
    Pasquini, E.
    Papi, M.
    Drudi, F.
    Tamburini, E.
    Genestreti, G.
    Nicoletti, S.
    Arcangeli, V
    Nicolini, M.
    Fabbri, P.
    Santo, A.
    Gianni, L.
    Fantini, M.
    Ravaioli, A.
    ANNALS OF ONCOLOGY, 2009, 20
  • [28] Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma
    Hasegawa, Seiki
    Yokoi, Kohei
    Okada, Morihito
    Tanaka, Fumihiro
    Shimokawa, Mototsugu
    Daimon, Takashi
    Nakano, Takashi
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 163 (06): : 1940 - +
  • [29] Adjuvant nivolumab with chemotherapy in pleural mesothelioma: The NICITA trial
    Shah, R.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1291 - S1292
  • [30] Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy
    Boeluekbas, Servet
    Manegold, Christian
    Eberlein, Michael
    Bergmann, Thomas
    Fisseler-Eckhoff, Annette
    Schirren, Joachim
    LUNG CANCER, 2011, 71 (01) : 75 - 81
12345